Search Results - "KURODA, HIROAKI"

Refine Results
  1. 1

    Differential Crizotinib Response Duration Among ALK Fusion Variants in ALK-Positive Non-Small-Cell Lung Cancer by Yoshida, Tatsuya, Oya, Yuko, Tanaka, Kosuke, Shimizu, Junichi, Horio, Yoshitsugu, Kuroda, Hiroaki, Sakao, Yukinori, Hida, Toyoaki, Yatabe, Yasushi

    Published in Journal of clinical oncology (01-10-2016)
    “…Anaplastic lymphoma kinase (ALK) rearrangement-positive non-small-cell lung cancers can be effectively treated with an ALK tyrosine kinase inhibitor (TKI) such…”
    Get full text
    Journal Article
  2. 2

    Four Hours Postoperative Mobilization is Feasible After Thoracoscopic Anatomical Pulmonary Resection by Nakada, Takeo, Shirai, Suguru, Oya, Yuko, Takahashi, Yusuke, Sakakura, Noriaki, Ohtsuka, Takashi, Kuroda, Hiroaki

    Published in World journal of surgery (01-02-2021)
    “…Background We aimed to analyze the feasibility and risk factors associated with early mobilization (EM) within 4 h after thoracoscopic lobectomy and…”
    Get full text
    Journal Article
  3. 3

    Comparison of Surgical Outcomes Between Invasive Mucinous and Non-Mucinous Lung Adenocarcinoma by Matsui, Takuya, Sakakura, Noriaki, Koyama, Shin, Nakanishi, Keita, Sasaki, Eiichi, Kato, Seiichi, Hosoda, Waki, Murakami, Yoshiko, Kuroda, Hiroaki, Yatabe, Yasushi

    Published in The Annals of thoracic surgery (01-10-2021)
    “…Invasive mucinous adenocarcinoma (IMA) is a rare subtype of invasive lung adenocarcinoma. However, the clinical course and prognostic outcomes following IMA…”
    Get full text
    Journal Article
  4. 4

    Efficacy of local therapy for oligoprogressive disease after programmed cell death 1 blockade in advanced non‐small cell lung cancer by Kagawa, Yusuke, Furuta, Hiromi, Uemura, Takehiro, Watanabe, Naohiro, Shimizu, Junichi, Horio, Yoshitsugu, Kuroda, Hiroaki, Inaba, Yoshitaka, Kodaira, Takeshi, Masago, Katsuhiro, Fujita, Shiro, Niimi, Akio, Hida, Toyoaki

    Published in Cancer science (01-12-2020)
    “…Immune checkpoint inhibitors (ICIs) have dramatically changed the strategy used to treat patients with non‐small‐cell lung cancer (NSCLC); however, the vast…”
    Get full text
    Journal Article
  5. 5

    Efficacy of Immune Checkpoint Inhibitor Monotherapy for Advanced Non-Small-Cell Lung Cancer with ALK Rearrangement by Oya, Yuko, Kuroda, Hiroaki, Nakada, Takeo, Takahashi, Yusuke, Sakakura, Noriaki, Hida, Toyoaki

    “…Programmed death-ligand 1 (PD-L1) expression is a predictor of immune checkpoint inhibitor (ICI) treatment efficacy. The clinical efficacy of ICIs for…”
    Get full text
    Journal Article
  6. 6

    Predictive clinical parameters for the response of nivolumab in pretreated advanced non-small-cell lung cancer by Oya, Yuko, Yoshida, Tatsuya, Kuroda, Hiroaki, Mikubo, Masashi, Kondo, Chiaki, Shimizu, Junichi, Horio, Yoshitsugu, Sakao, Yukinori, Hida, Toyoaki, Yatabe, Yasushi

    Published in Oncotarget (28-11-2017)
    “…Nivolumab offers a superior survival benefit over docetaxel in patients with advanced, previously treated non-small-cell lung cancer (NSCLC). An association…”
    Get full text
    Journal Article
  7. 7

    The Significance of the Prognostic Nutritional Index in Patients with Completely Resected Non-Small Cell Lung Cancer by Mori, Shunsuke, Usami, Noriyasu, Fukumoto, Koichi, Mizuno, Tetsuya, Kuroda, Hiroaki, Sakakura, Noriaki, Yokoi, Kohei, Sakao, Yukinori

    Published in PloS one (10-09-2015)
    “…Immunological parameters and nutritional status influence the outcome of patients with malignant tumors. A prognostic nutritional index, calculated using serum…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Biological Difference between L858R and Exon 19 Deletion Contributes to Recurrence-Free Survival of Resected Non-Small Cell Lung Cancer by Masago, Katsuhiro, Kuroda, Hiroaki, Fujita, Shiro, Sasaki, Eiichi, Takahashi, Yusuke, Shinohara, Shuichi, Matsushita, Hirokazu

    Published in Oncology (01-02-2023)
    “…The differences in biological characteristics among different genotypes of classical EGFR mutations have not been clarified. This study aimed to clarify the…”
    Get more information
    Journal Article
  10. 10
  11. 11

    The eighth TNM classification system for lung cancer: A consideration based on the degree of pleural invasion and involved neighboring structures by Sakakura, Noriaki, Mizuno, Tetsuya, Kuroda, Hiroaki, Arimura, Takaaki, Yatabe, Yasushi, Yoshimura, Kenichi, Sakao, Yukinori

    Published in Lung cancer (Amsterdam, Netherlands) (01-04-2018)
    “…•Prognostic difference between the T2a-PL1 and T2a-PL2 tumor groups was significant.•T2a-PL2 group could be categorized into a worse prognostic category…”
    Get full text
    Journal Article
  12. 12

    In Vivo Monitoring of Peripheral Circadian Clocks in the Mouse by Tahara, Yu, Kuroda, Hiroaki, Saito, Keisuke, Nakajima, Yoshihiro, Kubo, Yuji, Ohnishi, Nobuaki, Seo, Yasuhiro, Otsuka, Makiko, Fuse, Yuta, Ohura, Yuki, Komatsu, Takuya, Moriya, Youhei, Okada, Satoshi, Furutani, Naoki, Hirao, Akiko, Horikawa, Kazumasa, Kudo, Takashi, Shibata, Shigenobu

    Published in Current biology (05-06-2012)
    “…The mammalian circadian system is comprised of a central clock in the suprachiasmatic nucleus (SCN) and a network of peripheral oscillators located in all of…”
    Get full text
    Journal Article
  13. 13

    Negative reactions of BRAF mutation‐specific immunohistochemistry to non‐V600E mutations of BRAF by Seto, Katsutoshi, Haneda, Masataka, Masago, Katsuhiro, Fujita, Shiro, Kato, Seiichi, Sasaki, Eiichi, Hosoda, Waki, Murakami, Yoshiko, Kuroda, Hiroaki, Horio, Yoshitsugu, Hida, Toyoaki, Okubo, Kenichi, Yatabe, Yasushi

    Published in Pathology international (01-05-2020)
    “…BRAF mutations are rare driver mutations in non‐small cell lung cancer (NSCLC), accounting for 1%–2% of the driver mutations, and the mutation spectrum has a…”
    Get full text
    Journal Article
  14. 14

    Emergency rollout and conversion procedures during the three-arm robotic open-thoracotomy-view approach by Sakakura, Noriaki, Nakada, Takeo, Shirai, Suguru, Takahara, Hirotomo, Suzuki, Ayumi, Takahashi, Yusuke, Kuroda, Hiroaki

    “…To conduct robotic lung resections (RLRs) with views similar to those in open-thoracotomy surgery (OTS), we adopted a vertical port placement and confronting…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Micropapillary Predominance Is a Risk Factor for Brain Metastasis in Resected Lung Adenocarcinoma by Shigenobu, Takao, Takahashi, Yusuke, Masugi, Yohei, Hanawa, Ryutaro, Matsushita, Hirokazu, Tajima, Atsushi, Kuroda, Hiroaki

    Published in Clinical lung cancer (01-11-2021)
    “…Histologic subtyping offers some prognostic value in lung adenocarcinoma. We thus hypothesized that histologic subtypes may be useful for risk stratification…”
    Get full text
    Journal Article
  18. 18

    How preserved regional pulmonary function after thoracoscopic segmentectomy in clinical stage I non-small cell lung cancers in right upper lobe by Sugita, Yusuke, Kuroda, Hiroaki, Sakata, Shozou, Sakao, Yukinori, Okubo, Kenichi

    “…Objective To investigate the efficacy of regional respiratory preservation after pulmonary resection for clinical stage I non-small cell lung cancer (NSCLC) in…”
    Get full text
    Journal Article
  19. 19

    Brachial Artery Dissection Caused by Closed Elbow Dislocation in a Snowboarder : A Case Report and Review of Literature by Enokida, Shinpei, Nawata, Koji, Kuroda, Hiroaki, Otsuki, Takeo, Nagashima, Hideki

    Published in YONAGO ACTA MEDICA (2022)
    “…[ABSTRACT] This report describes a rare case of brachial artery dissection associated with closed elbow dislocation caused by a snowboarding injury. After…”
    Get full text
    Journal Article
  20. 20